Institutional investors purchased a net $36.5 million shares of TEVA during the quarter ended December 2016, and now own 60.77% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 23.5 Million shares of Teva Pharmaceutical
BLACKROCK FUND ADVISORS Bought 19.8 Million shares of Teva Pharmaceutical
HIGHFIELDS CAPITAL MANAGEMENT LP Bought 8.7 Million shares of Teva Pharmaceutical